Ownership history in Birchview Capital, LP Β· 7 quarters on record
This page tracks every 13F SEC filing in which Birchview Capital, LP reported a position in OUTSET MEDICAL INC (OM). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β sourced directly from SEC EDGAR 13F filings.
π Birchview Capital, LP underperformed the S&P 500 by β12.7% annually on this OM position. Timing score: 0% (0/4 decisions correct). Average cost basis: $15.84. Maximum drawdown during holding period: β80.7%.
β Significantly underperformed the S&P 500 by 12.7% ann.
5 quarters analyzed
β οΈ Poor timing β buys often preceded drops, trims preceded rallies.
0 of 4 add/trim decisions correct
Best entry: $3.71 (2025 Q4) Β· Worst: $19.21 (2025 Q2)
πͺ Held through 2 major drawdowns (>20%).
5 adds Β· 1 trim. Bought during 2 of 3 down-price quarters. π Consistently bullish β fund kept accumulating this position.
π Birchview Capital, LP has been actively increasing its OM allocation β a bullish signal from insiders.
Currently 0.21% of portfolio
β Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ 4 (annualised). Not investment advice.
As of 2025 Q4 β sorted by position size